The other study focuses on generating hybrid compounds of caffeic acid and resveratrol and assessing their capacity to inhibit two essential enzymes involved in Alzheimer’s disease: BACE 1 and acetylcholinesterase. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.